Canaccord Genuity Initiates Coverage On Immunocore Hldgs with Hold Rating, Announces Price Target of $67
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst Bill Maughan has initiated coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Hold rating and a price target of $67.
July 17, 2023 | 10:36 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Immunocore Hldgs (NASDAQ:IMCR) has been initiated with a Hold rating and a price target of $67 by Canaccord Genuity analyst Bill Maughan.
The Hold rating from Canaccord Genuity indicates that the analyst believes the stock is fairly valued at current levels. The price target of $67 suggests where the analyst believes the stock will trade in the future. This news could influence investor sentiment and trading behavior, but it does not necessarily indicate a significant change in the company's fundamentals.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100